| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Niroshan Jeyakumar, Magdalena Lerch, Russell C Dale, Sudarshini Ramanatha. MOG antibody-associated optic neuritis. Eye (London, England). 2024-05-23. PMID:38783085. |
mog antibody-associated optic neuritis. |
2024-05-23 |
2024-05-27 |
Not clear |
| Georgia A Wilke, Madeline Spencer, Carley A Gilman, Rejean Guerriero, Parker Bohm, Gregory P Van Stavern, Andrew R Le. Peripheral Retinal Haemorrhages in a Patient with MOG-Associated Optic Neuritis. Neuro-ophthalmology (Aeolus Press). vol 48. issue 3. 2024-05-18. PMID:38756341. |
ultimately, she was found to be positive for myelin oligodendrocyte glycoprotein (mog) antibodies, consistent with a diagnosis of mog-associated optic neuritis. |
2024-05-18 |
2024-05-27 |
Not clear |
| Barbara Nowacka, Wojciech Lubiński, Beata Kaźmiercza. Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Optic Neuritis - A Case Report and Literature Review. International medical case reports journal. vol 17. 2024-05-06. PMID:38708316. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated optic neuritis - a case report and literature review. |
2024-05-06 |
2024-05-08 |
Not clear |
| Barbara Nowacka, Wojciech Lubiński, Beata Kaźmiercza. Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Optic Neuritis - A Case Report and Literature Review. International medical case reports journal. vol 17. 2024-05-06. PMID:38708316. |
myelin oligodendrocyte glycoprotein (mog)-igg-associated optic neuritis (on) is a new subset of demyelinating optic neuropathy. |
2024-05-06 |
2024-05-08 |
Not clear |
| Aniruddh Heroor, Mudit Tyagi, Ramesh Kekunnaya, Goura Chattannava. Paracentral acute middle maculopathy in a patient with Myelin Oligodendrocyte glycoprotein antibody associated optic neuritis. American journal of ophthalmology case reports. vol 34. 2024-04-29. PMID:38680528. |
in this case report, we present a distinctive instance of optic neuritis with a positive myelin oligodendrocyte glycoprotein (mog) antibody, accompanied by retinal ischemia manifesting as paracentral acute middle maculopathy (pamm) lesions. |
2024-04-29 |
2024-05-01 |
Not clear |
| Yoji Hoshina, Meagan Seay, Sravanthi Vegunta, Eric L Stulberg, Melissa A Wright, Ka-Ho Wong, Tammy L Smith, Daisuke Shimura, Stacey L Clard. Isolated Optic Neuritis: Etiology, Characteristics, and Outcomes in a US Mountain West Cohort. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2024-04-22. PMID:38644536. |
the diagnosis and treatment of autoimmune optic neuritis (on) has improved with the accessibility and reliability of aquaporin-4 (aqp4) and myelin oligodendrocyte glycoprotein (mog) antibody testing, yet autoantibody-negative on remains common. |
2024-04-22 |
2024-04-24 |
Not clear |
| Juan Zhao, Xiaoli Chen, Jingxiao Zhang, Lei Liu, Jiawei Wang, Liping Zh. Isolated myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in adults: The importance of age of onset and prognosis-related radiological features. Multiple sclerosis and related disorders. vol 85. 2024-03-06. PMID:38447395. |
however, less is known about whether the manifestations of isolated mog antibody-associated optic neuritis (imog-on) vary across different age groups. |
2024-03-06 |
2024-03-09 |
Not clear |
| Ryan D Sorensen, Ashtyn Vogt, Noor Laylani, Mohammad Pakravan, Andrew G Le. Myelin oligodendrocyte glycoprotein (MOG) associated optic neuritis in a patient with idiopathic intracranial hypertension (IIH) and compressive optic neuropathy case report. BMC ophthalmology. vol 24. issue 1. 2024-02-13. PMID:38350984. |
myelin oligodendrocyte glycoprotein (mog) associated optic neuritis in a patient with idiopathic intracranial hypertension (iih) and compressive optic neuropathy case report. |
2024-02-13 |
2024-02-16 |
Not clear |
| Takashi Saito, Rieko Suzuki, Noboru Imai, Masahiro Serizaw. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) Following Adenovirus Meningitis After First Delivery: Case Report and Literature Review. Cureus. vol 15. issue 11. 2023-12-07. PMID:38060760. |
myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) is a group of central nervous system (cns) demyelinating diseases caused by autoantibodies against myelin oligosaccharide protein (mog), a myelin sheath component protein, and present with a variety of symptoms, including optic neuritis, myelitis, acute disseminated encephalomyelitis (adem), brainstem encephalitis, and corticobasal encephalitis. |
2023-12-07 |
2023-12-17 |
Not clear |
| Chuan-Bin Su. Prevalence of serum MOG antibody and AQP4 antibody in optic neuritis after SARS-CoV-2 infection. Frontiers in immunology. vol 14. 2023-12-06. PMID:38054007. |
prevalence of serum mog antibody and aqp4 antibody in optic neuritis after sars-cov-2 infection. |
2023-12-06 |
2023-12-10 |
Not clear |
| Mohamad Azlan Zaini, Ayesha Mohd Zain, Norshamsiah Md Din, Chenshen La. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a post-COVID-19 infection patient. Immunity, inflammation and disease. vol 11. issue 10. 2023-10-31. PMID:37904693. |
we report a case of myelin oligodendrocyte glycoprotein (mog) related optic neuritis in a sars-cov-2 (covid-19) patient. |
2023-10-31 |
2023-11-08 |
Not clear |
| Min Shi, Danqing Luo, Zhaoying Li, Man Li, Shuoguo Jin, Dongdong Yang, Jun Guo, Guo Che. A case report of neurosyphilis coexisting with a positive MOG antibody manifested as optic neuritis. Frontiers in neurology. vol 14. 2023-10-20. PMID:37859651. |
a case report of neurosyphilis coexisting with a positive mog antibody manifested as optic neuritis. |
2023-10-20 |
2023-11-08 |
Not clear |
| Ankit Bhardwaj, Hara Prasad Mishra, Ayush Goel, Ashi Gupt. COVID-19 - a potential trigger for MOGAD-associated optic neuritis: a case report and literature review. Therapeutic advances in ophthalmology. vol 15. 2023-10-09. PMID:37808590. |
we are reporting a case of a middle-aged adult diagnosed with myelin oligodendrocyte glycoprotein (mog) antibody-positive optic neuritis of the right eye post-covid-19 disease. |
2023-10-09 |
2023-10-15 |
Not clear |
| Ankit Bhardwaj, Hara Prasad Mishra, Ayush Goel, Ashi Gupt. COVID-19 - a potential trigger for MOGAD-associated optic neuritis: a case report and literature review. Therapeutic advances in ophthalmology. vol 15. 2023-10-09. PMID:37808590. |
a diagnosis of mog antibody-positive optic neuritis was made, and the patient was treated with an injection of methylprednisolone with intravenous immunoglobulin. |
2023-10-09 |
2023-10-15 |
Not clear |
| Keiko Tanaka, Takeshi Kezuka, Hitoshi Ishikawa, Masami Tanaka, Kenji Sakimura, Manabu Abe, Meiko Kawamur. Pathogenesis, Clinical Features, and Treatment of Patients with Myelin Oligodendrocyte Glycoprotein (MOG) Autoantibody-Associated Disorders Focusing on Optic Neuritis with Consideration of Autoantibody-Binding Sites: A Review. International journal of molecular sciences. vol 24. issue 17. 2023-09-09. PMID:37686172. |
pathogenesis, clinical features, and treatment of patients with myelin oligodendrocyte glycoprotein (mog) autoantibody-associated disorders focusing on optic neuritis with consideration of autoantibody-binding sites: a review. |
2023-09-09 |
2023-10-07 |
mouse |
| Keiko Tanaka, Takeshi Kezuka, Hitoshi Ishikawa, Masami Tanaka, Kenji Sakimura, Manabu Abe, Meiko Kawamur. Pathogenesis, Clinical Features, and Treatment of Patients with Myelin Oligodendrocyte Glycoprotein (MOG) Autoantibody-Associated Disorders Focusing on Optic Neuritis with Consideration of Autoantibody-Binding Sites: A Review. International journal of molecular sciences. vol 24. issue 17. 2023-09-09. PMID:37686172. |
several studies have identified two mog epitopes that exhibit strong affinity with human anti-mog autoantibodies, particularly those isolated from patients with the optic neuritis phenotype. |
2023-09-09 |
2023-10-07 |
mouse |
| Xuelian Chen, Libo Cheng, Ying Pan, Peng Chen, Yidan Luo, Shiyi Li, Wenjun Zou, Ke Wan. Corrigendum: Different immunological mechanisms between AQP4 antibody-positive and MOG antibody-positive optic neuritis based on RNA sequencing analysis of whole blood. Frontiers in immunology. vol 14. 2023-09-04. PMID:37662934. |
corrigendum: different immunological mechanisms between aqp4 antibody-positive and mog antibody-positive optic neuritis based on rna sequencing analysis of whole blood. |
2023-09-04 |
2023-09-07 |
Not clear |
| D D Eliseeva, A K Kalashnikova, V V Bryukhov, N A Andreeva, N V Zhorzholadze, Yu K Murakhovskaya, T D Krilova, P G Tsygankova, M N Zakharova, N L Shereme. [Hereditary optic neuropathy associated with demyelinating diseases of the central nervous system]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 123. issue 7. Vyp. 2. 2023-08-10. PMID:37560844. |
optic neuritis can occur at the onset or be one of the syndromes within multiple sclerosis (ms), neuromyelitis optica spectrum disorders (nmosd), and myelin oligodendrocyte glycoprotein (mog) antibody disease (mogad). |
2023-08-10 |
2023-08-16 |
Not clear |
| Jessica A Kraker, John J Che. An update on optic neuritis. Journal of neurology. 2023-08-05. PMID:37542657. |
although most cases of optic neuritis (on) are classified as typical, meaning idiopathic or associated with multiple sclerosis, there is a growing understanding of atypical forms of optic neuritis such as antibody mediated aquaporin-4 (aqp4)-igg neuromyelitis optica spectrum disorder (nmosd) and the recently described entity, myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad). |
2023-08-05 |
2023-08-14 |
Not clear |
| Tomoko Tanaka, Masaya Togo, Kiminobu Okayama, Norio Chihara, Takehiro Ueda, Kenji Sekiguchi, Riki Matsumot. [Cingulate seizure as a clinical manifestation of anti-myelin oligodendrocyte glycoprotein antibody-positive cerebral cortical encephalitis of two cases]. Rinsho shinkeigaku = Clinical neurology. 2023-07-02. PMID:37394493. |
the first case, a 20-year-old man had been treated with steroids for anti-myelin oligodendrocyte glycoprotein (mog) antibody-positive optic neuritis. |
2023-07-02 |
2023-08-14 |
Not clear |